Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Immune privilege collapse in hair follicles may cause permanent hair loss in certain conditions.

Hair follicles could help develop eye treatments by studying immune responses.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

ILC1 cells contribute to hair loss in alopecia areata.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Dandruff is linked to changes in the immune system of hair follicles and skin.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Electrical epilation damages hair follicles and surrounding skin, likely preventing hair regrowth.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Nanotechnology shows promise for better drug delivery and cancer treatment.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.